Domov › Akútna myeloidná leukémia › New York › Queens
Klinické štúdie Akútna myeloidná leukémia v meste Queens, NY
21 štúdií pre Akútna myeloidná leukémia hľadá účastníkov v zariadeniach v meste Queens a okolí (do cca 30 míľ). Otvorte štúdiu a zistite, kto sa môže zapojiť a ako kontaktovať tím.
Oficiálny text štúdie (anglicky)
Hľadáte účastníkov do štúdie? Zvýraznite ju na začiatku tejto stránky – $99 na 30 dní →
MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)
Prebieha náborFáza 2
- Northwell Health/Center for Advanced Medicine, Lake Success · 9 míľ odtiaľ
- Memorial Sloan Kettering Nassau, Uniondale · 13 míľ odtiaľ
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Prebieha náborObservačná štúdiaVítaní zdravých dobrovoľníkov
- Queens Hospital Center, Jamaica · 2 míľ odtiaľ
Testing the Anti-cancer Drug, Cirtuvivint, and Its Combination With ASTX727 to Improve Outcomes in Patients With Acute Myeloid Leukemia and Myelodysplastic Syndromes
Prebieha náborFáza 1
- Memorial Sloan Kettering Nassau, Uniondale · 13 míľ odtiaľ
Comparing Cytarabine + Daunorubicin Therapy Versus Cytarabine + Daunorubicin + Venetoclax Versus Venetoclax + Azacitidine in Younger Patients With Intermediate Risk AML (A MyeloMATCH Treatment Trial)
Prebieha náborFáza 2
- Memorial Sloan Kettering Nassau, Uniondale · 13 míľ odtiaľ
Comparing New Treatments for People With Newly Diagnosed Acute Myeloid Leukemia That Has an IDH2 Gene Change (A MyeloMATCH Treatment Trial)
Prebieha náborFáza 2
- Memorial Sloan Kettering Nassau, Uniondale · 13 míľ odtiaľ
Testing New Therapies for Patients With Acute Myeloid Leukemia Who Are Newly Diagnosed and Have Not Yet Started Treatment (A MyeloMATCH Treatment Trial)
Prebieha náborFáza 2
- Northwell Health/Center for Advanced Medicine, Lake Success · 9 míľ odtiaľ
- Memorial Sloan Kettering Nassau, Uniondale · 13 míľ odtiaľ
A Study of CRD3874-SI in People With Leukemia
Prebieha náborFáza 1
- Memorial Sloan Kettering Nassau (All Protocol Activities), Rockville Centre · 10 míľ odtiaľ
Venetoclax and HMA Treatment of Older and Unfit Adults With FLT3 Mutated Acute Myeloid Leukemia (AML) (A MyeloMATCH Treatment Trial)
Prebieha náborFáza 2
- Northwell Health/Center for Advanced Medicine, Lake Success · 9 míľ odtiaľ
A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for Patients With Newly Diagnosed AML With or Without FLT3 Mutations
Prebieha náborFáza 3
- The Steven and Alexandra Cohen Children's Medical Center of New York, New Hyde Park · 9 míľ odtiaľ
- NYU Langone Hospital - Long Island, Mineola · 11 míľ odtiaľ
Evaluation of Two Dose Levels of Quizartinib as Maintenance in FLT3-ITD (+) Acute Myeloid Leukemia Patients in Complete Remission
Prebieha náborFáza 2
- Clinical Research Allicance, Westbury · 14 míľ odtiaľ
The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study
Prebieha náborFáza 1/2
- The Steven and Alexandra Cohen Children's Medical Center of New York, New Hyde Park · 9 míľ odtiaľ
- NYU Langone Hospital - Long Island, Mineola · 11 míľ odtiaľ
Venetoclax in Children With Relapsed Acute Myeloid Leukemia (AML)
Prebieha náborFáza 3
- Cohen Children's Medical Center, Queens
Safety and Tolerability of Ziftomenib Combinations in Patients With Relapsed/Refractory Acute Myeloid Leukemia
Prebieha náborFáza 1
- Northwell Health, LLC PRIME, Lake Success · 9 míľ odtiaľ
A Study of the Combination of Ivosidenib, Azacitidine, and Venetoclax Followed by Ivosidenib Alone in People With Acute Myeloid Leukemia
Prebieha náborFáza 2
- Memorial Sloan Kettering Nassau (Limited Protocol Activites), Rockville Centre · 10 míľ odtiaľ
A Study of Revumenib and Mezigdomide in People With Leukemia
Prebieha náborFáza 1/2
- Memorial Sloan Kettering Nassau (All Protocol Activities), Rockville Centre · 10 míľ odtiaľ
A Study of CD371-YSNVZIL-18 CAR T Cells in People With Acute Myeloid Leukemia
Prebieha náborFáza 1
- Memorial Sloan Kettering Nassau (Limited Protocol Activites), Rockville Centre · 10 míľ odtiaľ
A Study of Gilteritinib in Combination With Ivosidenib or Enasidenib in People With Acute Myeloid Leukemia (AML)
Prebieha náborFáza 1
- Memorial Sloan Kettering Nassau, Uniondale · 13 míľ odtiaľ
A Study of Natural Killer Cells in Combination With Atezolizumab in People With Acute Myelogenous Leukemia
Prebieha náborFáza 1
- Memorial Sloan Kettering Nassau (Limited Protocol Activites), Rockville Centre · 10 míľ odtiaľ
A Multi-phase Study of ASTX030 (Azacitidine and Cedazuridine) in Myeloid Neoplasm Alone or in Combination With Venetoclax in AML (AZTOUND Study)
Prebieha náborFáza 2/3
- New York University Langone Hospital - Long Island, Mineola · 11 míľ odtiaľ
A Study of ADCLEC.syn1 in People With Acute Myeloid Leukemia
Prebieha náborFáza 1
- Memorial Sloan Kettering Nassau (Limited Protocol Activities), Uniondale · 13 míľ odtiaľ
A Study of Azacitidine and Venetoclax in People With Acute Myeloid Leukemia (AML)
Prebieha náborFáza 2
- Memorial Sloan Kettering Nassau (All Protocol Activities), Rockville Centre · 10 míľ odtiaľ
Štúdie Akútna myeloidná leukémia v iných mestách
- Houston, TX85 štúdií
- New York City, NY51 štúdií
- Boston, MA44 štúdií
- Seattle, WA41 štúdií
- Baldwin Park, CA40 štúdií
- Columbus, OH35 štúdií
- Philadelphia, PA34 štúdií
- Durham, NC33 štúdií
- Atlanta, GA31 štúdií
- Tampa, FL29 štúdií
- Chicago, IL26 štúdií
- Portland, OR25 štúdií
Iné štúdie v Queens
- Rakovina prsníka64 štúdií
- Nemalobunkový karcinóm pľúc49 štúdií
- Kolorektálny karcinóm31 štúdií
- Metastatická rakovina28 štúdií
- Rakovina vaječníkov28 štúdií
- Rakovina prostaty27 štúdií
- Rakovina (všetky typy)26 štúdií
- Rakovina endometria25 štúdií
- Rakovina pľúc22 štúdií
- Mnohonásobný myelóm20 štúdií
- Rakovina pankreasu20 štúdií
- Skvamóznocelulárny karcinóm hlavy a krku20 štúdií
Z ClinicalTrials.gov, dáta načítané 6. 10. 2026. Každá štúdia má vlastné kritériá oprávnenosti; tím štúdie rozhoduje o účasti.